{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:34:02Z","timestamp":1758710042271,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32-AI060549)"],"award-info":[{"award-number":["T32-AI060549)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.virol.2016.05.024","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T06:15:39Z","timestamp":1465280139000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III"],"prefix":"10.1016","volume":"496","author":[{"given":"Jessica A.","family":"Plante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricela","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire Y.-H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.C.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2016.05.024_bib1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.vaccine.2010.12.081","article-title":"Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease","volume":"29","author":"Alonso-Padilla","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2016.05.024_bib2","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1099\/vir.0.032318-0","article-title":"North American West Nile virus genotype isolates demonstrate differential replicative capacities in response to temperature","volume":"92","author":"Andrade","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.virol.2011.06.006","article-title":"Molecular evolution of West Nile virus in a northern temperate region: Connecticut, USA 1999\u20132008","volume":"417","author":"Armstrong","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.07.018","article-title":"Phylogenetic characterization of Central\/Southern European lineage 2 West Nile virus: analysis of human outbreaks in Italy and Greece, 2013\u20132014","volume":"21","author":"Barzon","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.virol.2016.05.024_bib5","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00150-8","article-title":"Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States","volume":"309","author":"Beasley","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib7","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.42.6.2759-2765.2004","article-title":"Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection","volume":"42","author":"Beasley","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2016.05.024_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/viro.2002.1372","article-title":"Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype","volume":"296","author":"Beasley","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib9","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1128\/JVI.79.13.8339-8347.2005","article-title":"Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains","volume":"79","author":"Beasley","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virusres.2006.09.002","article-title":"The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization","volume":"123","author":"Choi","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2016.05.024_bib12","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2016.05.024_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/vir.0.80411-0","article-title":"Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein","volume":"86","author":"Chu","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib14","doi-asserted-by":"crossref","first-page":"e4991","DOI":"10.1371\/journal.pone.0004991","article-title":"Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens","volume":"4","author":"Crill","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2016.05.024_bib15","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib16","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1128\/JVI.02387-06","article-title":"A combination of naturally occurring mutations in North American West Nile virus nonstructural protein genes and in the 3\u2032 untranslated region alters virus phenotype","volume":"81","author":"Davis","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib17","doi-asserted-by":"crossref","first-page":"e1004738","DOI":"10.1371\/journal.ppat.1004738","article-title":"Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding","volume":"11","author":"de Fabritus","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.05.024_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1743-422X-7-95","article-title":"Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice","volume":"7","author":"Dunn","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2016.05.024_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2010.07.024","article-title":"Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes","volume":"406","author":"Erb","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1743-422X-11-60","article-title":"Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus","volume":"11","author":"Huang","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2016.05.024_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","article-title":"An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells","volume":"78","author":"Hung","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib22","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1128\/JVI.75.16.7692-7702.2001","article-title":"Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein","volume":"75","author":"Hurrelbrink","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib23","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib24","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.0914503107","article-title":"Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.05.024_bib25","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1128\/JVI.78.15.8271-8280.2004","article-title":"Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses","volume":"78","author":"Lee","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib26","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1128\/JVI.74.19.8867-8875.2000","article-title":"Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1074\/jbc.M506614200","article-title":"Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.05.024_bib28","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1128\/JVI.02340-13","article-title":"The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states","volume":"87","author":"Lee","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2005.02.011","article-title":"Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains","volume":"335","author":"Li","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib30","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1371\/journal.pntd.0001447","article-title":"Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay","volume":"6","author":"Lin","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib31","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JVI.06435-11","article-title":"A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus","volume":"86","author":"Lin","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib32","first-page":"1","article-title":"Surveillance for human West Nile virus disease - United States, 1999\u20132008","volume":"59","author":"Lindsey","year":"2010","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.virol.2016.05.024_bib33","unstructured":"MacroGenics, 2009. A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults, \u3008ClinicalTrials.Gov NCT00515385\u3009."},{"key":"10.1016\/j.virol.2016.05.024_bib34","unstructured":"MacroGenics, 2012. Treatment of West Nile Virus With MGAWN1 (PARADIGM), \u3008ClinicalTrials.gov NCT00927953\u3009."},{"key":"10.1016\/j.virol.2016.05.024_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2016.05.024_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1099\/vir.0.046888-0","article-title":"Molecular evolution of lineage 2 West Nile virus","volume":"94","author":"McMullen","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/13550280801958930","article-title":"West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons","volume":"14","author":"Morrey","year":"2008","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.virol.2016.05.024_bib38","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.05.024_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2016.05.024_bib41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid1705.101759","article-title":"Genetic characterization of West Nile virus lineage 2, Greece, 2010","volume":"17","author":"Papa","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3201\/eid2002.131008","article-title":"Co-circulation of West Nile virus variants, Arizona, USA, 2010","volume":"20","author":"Plante","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib43","first-page":"29","article-title":"Genotyping of West Nile fever virus strains circulating in southern Russia as an epidemiological investigation method: principles and results","author":"Platonov","year":"2011","journal-title":"Zhurnal Mikrobiol. Epidemiol. Immunobiol."},{"key":"10.1016\/j.virol.2016.05.024_bib44","doi-asserted-by":"crossref","first-page":"15066","DOI":"10.1073\/pnas.1206598109","article-title":"Unifying the spatial epidemiology and molecular evolution of emerging epidemics","volume":"109","author":"Pybus","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.05.024_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.virusres.2011.03.023","article-title":"Neutralization escape variant of West Nile virus associated with altered peripheral pathogenicity and differential cytokine profile","volume":"158","author":"Sapkal","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2016.05.024_bib46","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/518281","article-title":"The long-term outcomes of human West Nile virus infection","volume":"44","author":"Sejvar","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib47","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1502864112","article-title":"Large-scale recoding of an arbovirus genome to rebalance its insect versus mammalian preference","volume":"112","author":"Shen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.05.024_bib48","first-page":"16","article-title":"Outbreak of West Nile virus infection in humans, Romania, July to October 2010","author":"Sirbu","year":"2011","journal-title":"Eur. Surveill."},{"key":"10.1016\/j.virol.2016.05.024_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2011.04.011","article-title":"Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1","volume":"91","author":"Smeraski","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2016.05.024_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1743-422X-7-146","article-title":"A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice","volume":"7","author":"Spohn","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2016.05.024_bib51","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.05.024_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3201\/eid1603.091033","article-title":"Putative new lineage of west nile virus, Spain","volume":"16","author":"Vazquez","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/vbz.2009.0230","article-title":"West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa","volume":"10","author":"Venter","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib54","doi-asserted-by":"crossref","first-page":"38755","DOI":"10.1074\/jbc.M402385200","article-title":"Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus","volume":"279","author":"Volk","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.05.024_bib55","doi-asserted-by":"crossref","first-page":"e1003458","DOI":"10.1371\/journal.ppat.1003458","article-title":"Dissection of antibody specificities induced by yellow fever vaccination","volume":"9","author":"Vratskikh","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2016.05.024_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2011.11.022","article-title":"Mutational analysis of the West Nile virus NS4B protein","volume":"426","author":"Wicker","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2006.03.007","article-title":"A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice","volume":"349","author":"Wicker","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib58","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3201\/eid1812.111208","article-title":"West Nile virus neurologic disease in humans, South Africa, September 2008-may 2009","volume":"18","author":"Zaayman","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2016.05.024_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2010.03.038","article-title":"Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III","volume":"403","author":"Zhang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.05.024_bib60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/599794","article-title":"Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus","volume":"200","author":"Zhang","year":"2009","journal-title":"J. Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216301337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216301337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:36:50Z","timestamp":1758587810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682216301337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":59,"alternative-id":["S0042682216301337"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.05.024","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}